FibroGen Inc (FGEN)
0.3954
+0.01
(+2.12%)
USD |
NASDAQ |
Nov 22, 16:00
0.40
0.00 (0.00%)
After-Hours: 20:00
FibroGen Total Return Price: 0.3954 for Nov. 22, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
November 22, 2024 | 0.3954 |
November 21, 2024 | 0.3872 |
November 20, 2024 | 0.35 |
November 19, 2024 | 0.35 |
November 18, 2024 | 0.3374 |
November 15, 2024 | 0.3347 |
November 14, 2024 | 0.3699 |
November 13, 2024 | 0.3322 |
November 12, 2024 | 0.3866 |
November 11, 2024 | 0.3386 |
November 08, 2024 | 0.323 |
November 07, 2024 | 0.3128 |
November 06, 2024 | 0.3104 |
November 05, 2024 | 0.307 |
November 04, 2024 | 0.3254 |
November 01, 2024 | 0.3189 |
October 31, 2024 | 0.3014 |
October 30, 2024 | 0.3178 |
October 29, 2024 | 0.3062 |
October 28, 2024 | 0.2988 |
October 25, 2024 | 0.308 |
October 24, 2024 | 0.32 |
October 23, 2024 | 0.32 |
October 22, 2024 | 0.3503 |
October 21, 2024 | 0.3745 |
Date | Value |
---|---|
October 18, 2024 | 0.3915 |
October 17, 2024 | 0.395 |
October 16, 2024 | 0.3757 |
October 15, 2024 | 0.3544 |
October 14, 2024 | 0.3431 |
October 11, 2024 | 0.3573 |
October 10, 2024 | 0.337 |
October 09, 2024 | 0.3277 |
October 08, 2024 | 0.3284 |
October 07, 2024 | 0.3426 |
October 04, 2024 | 0.3667 |
October 03, 2024 | 0.3989 |
October 02, 2024 | 0.3999 |
October 01, 2024 | 0.392 |
September 30, 2024 | 0.3994 |
September 27, 2024 | 0.4064 |
September 26, 2024 | 0.3916 |
September 25, 2024 | 0.373 |
September 24, 2024 | 0.3837 |
September 23, 2024 | 0.3721 |
September 20, 2024 | 0.4086 |
September 19, 2024 | 0.416 |
September 18, 2024 | 0.42 |
September 17, 2024 | 0.4481 |
September 16, 2024 | 0.4522 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
0.2988
Minimum
Oct 28 2024
55.72
Maximum
Feb 12 2021
18.40
Average
14.24
Median
Total Return Price Benchmarks
Biomarin Pharmaceutical Inc | 64.26 |
Arbutus Biopharma Corp | 3.51 |
GlycoMimetics Inc | 0.3168 |
Cidara Therapeutics Inc | 20.40 |
Cue Biopharma Inc | 1.02 |